
|Videos|November 13, 2020
(AAO) Genentech provides update on presentations, product portfolio
Author(s)OT Staff Reports, Sheryl Stevenson
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Advertisement
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: Optimizing the ocular surface for light adjustable lens technology
2
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
3
PRIMA System: A major step in the battle against GA
4
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
5




























